Determination of isosteviol by LC-MS/MS and its application for evaluation of pharmacokinetics of isosteviol in rat

Daru

Volumn 15, Issue 3, 2007, Pages 146-150

  Bazargan, M ^a,b   Gerber, J P ^a   Wang, J ^a   Chitsaz, M ^c   Milne, R W ^a   Evans, A M ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHED UNIVERSITY   (Iran)

Author keywords

Isosteviol; LC MS MS; Pharmacokinetics; Rats

Indexed keywords

ISOSTEVIOL; NITROGEN; PROGESTERONE; STEVIOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DETERMINATION; DRUG HALF LIFE; ELECTROSPRAY; JUGULAR VEIN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; RAT; SPRAGUE DAWLEY RAT; STANDARD;

EID: 35848940708     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Soejarto DD, Kinghorn AD, Farnsworth NR. Potential sweetening agents of plant origin. III. Organoleptic evaluation of stevia leaf herbarium samples for sweetness. J Nat Prod 1982;45(5):590-99.
2. Kinghorn AD. Highly sweet compounds from North and South American medicinal zplants. Saengyak Hakhoechi 1991;22(1):1-12.
3. Hsieh M-H, Chan P, Sue Y-M, Liu J-C, Liang TH, Huang T-Y, et al. Efficacy and tolerability of oral stevioside in patients with mild essential hypertension: a two-year, randomized, placebo-controlled study. Clinical Therapeutics 2003;25(11):2797-2808.
4. Lailerd N, Saengsirisuwan V, Sloniger JA, Toskulkao C, Henriksen EJ. Effects of stevioside on glucose transport activity in insulin-sensitive and insulin-resistant rat skeletal muscle. Meta, Clin and Exp 2004;53(1):101-107.
5. Korochkina M, Fontanella M, Casnati A, Arduini A, Sansone F, Ungaro R, et al. Synthesis and spectroscopic studies of isosteviol-calix[4]arene and -calix[6]arene conjugates. Tetrahedron 2005;61(23):5457-5463.
6. Bracht AK, Alvarez M, Bracht A. Effects of Stevia rebaudiana natural products on rat liver mitochondria. Biochem Pharmacol 1985;34(6):873-82.
7. Pezzuto JM, Compadre CM, Swanson SM, Nanayakkara NPD, Kinghorn AD. Metabolically activated steviol, the aglycone of stevioside, is mutagenic. Proc Natl Acad Sci U S A 1985;82(8):2478-82.
8. Wong KL, Lin JW, Liu JC, Yang HY, Kao PF, Chen Ch, Loh SH. Antiproliferative effect of isosteviol on angiotensin-II-treated rat aortic smooth muscle cells. Pharmacology. 2006;76(4):163-9.
9. Yamamoto NS, Kelmer Bracht AM, Ishii EL, Kemmelmeier FS, Alvarez M, Bracht A. Effect of steviol and its structural analogues on glucose production and oxygen uptake in rat renal tubules. Experientia 1985;41(1):55-7.
10. Xu D, Li Y, Wang J, Davey AK, Zhang S, Evans AM. The cardioprotective effect of isosteviol on rats with heart ischemia-reperfusion injury. Life Sci. 2007 ;80(4):269-74.
11. Liu JC, Kao PF, Hsieh MH, Chen YJ, Chan P. The antihypertensive effects of stevioside derivative isosteviol in spontaneously hypertensive rats. Acta Cardiol Sinica 2001;17:133-140.
12. Mizushina Y, Akihisa T, Ukiya M, Hamasaki Y, murakami-nakai C, Kuriyama I. Structural analysis of isosteviol and related compounds as DNA polymerase and DNA topoisomerase inhibitors. Life Sci 2005;77(17):2127-40
13. Yasukawa K, Kitanaka S, Seo S. Inhibitory effect of stevioside on tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin. Chem Pharm Bull 2002;25(11):1488-1490.
14. Akihisa T, Hamasaki Y, Tokuda H, Ukiya M, Kimura Y, Nishino H. Microbial Transformation of isosteviol and inhibitory effects on Epstein-Barr virus activation of the transformation products. J Nat Prod 2004;67(3):407-410.